Stay updated with breaking news from Michaelk Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEATTLE, March 11, 2024 -- Perspective Therapeutics, Inc. , a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that...
Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...
SEATTLE, Nov. 14, 2023 -- Perspective Therapeutics, Inc. , today announced third quarter financial results for the period ended September 30, 2023 and provided recent business highlights.. ...
RICHLAND, WASH. & CORALVILLE, IOWA, Aug. 30, 2023 -- Perspective Therapeutics, Inc. , today announced that it will have two presentations at the upcoming World Molecular Imaging Congress 2023,...
SBIR Phase II Grants bring the cumulative grant total to approximately $17 million from the National Institutes of Health and National Cancer InstituteCORALVILLE, IA / ACCESSWIRE / October 11, 2022 / Viewpoint